More exciting news from Coastal Vascular & Interventional, PLLC! Coastal Vascular & Interventional announces its participation in VISION, a global clinical trial approved by the FDA to evaluate Avinger’s PantherisTM catheter for treatment of Peripheral Arterial Disease (PAD). Coastal Vascular & Interventional is the first in the United States to treat patients using the Pantheris catheter in an outpatient center. Huey B. McDaniel, M.D., Stuart Harlin, M.D., and Christopher LeCroy, M.D., board certified vascular surgeons at Coastal Vascular & Interventional, as part of VISION, will treat enrolled patients using PantherisTM, a system that combines directional atherectomy capabilities with real-time intravascular visualization to remove plaque from blocked arteries. The minimally invasive catheter is designed to remove the blockage while avoiding the disruption of normal arterial wall structures. “Now we have this wonderful technology to be able to see several millimeters into what would be opaque tissue, just like the way ultrasound does but much, much higher resolution. Using this technology you’re basically able to do vascular surgery on a minimally invasive basis,” says Dr. Huey B. McDaniel, principal investigator. Dr. Stuart Harlin, sub-investigator, explains “The new technology available allows precision in treatment of PAD that was previously unattainable. Providing this technology in an outpatient setting ushers in a new era in the treatment of patients with PAD.”
Posted on: Tue, 30 Dec 2014 14:02:37 +0000
Trending Topics
Recently Viewed Topics
© 2015